NCT06578507 Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children With Sickle Cell Disease Status RECRUITING Phase PHASE2
NCT06563440 Development and Evaluation of an Information Management System and Communication System for Population-wide Point-of-care Infant Sickle Cell Disease Screening Status NOT_YET_RECRUITING Phase NA
NCT06562439 Testing the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) Intervention Status NOT_YET_RECRUITING Phase NA
NCT06561061 Zinc for Infection Prevention in Sickle Cell Anemia-2 (ZIPS-2) Status COMPLETED Phase PHASE2/PHASE3
NCT06555939 Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease Status RECRUITING Phase NA
NCT06546670 A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease Status RECRUITING Phase PHASE1/PHASE2
NCT06539169 FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases Status RECRUITING Phase N/A
NCT06503458 A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell Participants Status TERMINATED Phase N/A
NCT06477289 Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease Status RECRUITING Phase N/A
NCT06464458 Optimizing the Management of Sickle Cell Patients on Hydroxyurea: The Value of Therapeutic Pharmacological Monitoring Status RECRUITING Phase NA
NCT06442761 SCD Stem Cell Mobilization and Apheresis Using Motixafortide Status RECRUITING Phase PHASE1
NCT06439082 A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) Status RECRUITING Phase PHASE3
NCT06399107 Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease Status RECRUITING Phase PHASE1/PHASE2